Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 413-419

  Ndikum Moffor, Florence M ^a   Schoeb, Trenton R ^a   Roberts, Stephen M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHLORAMPHENICOL; CIMETIDINE; COCAINE; CORN OIL; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DIMPYLATE; DRUG METABOLITE; DRUG VEHICLE; ESTERASE INHIBITOR; KETOCONAZOLE; NITROXIDE DERIVATIVE; NORCOCAINE; PHENOBARBITAL; PROADIFEN; SODIUM CHLORIDE; TROLEANDOMYCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG OXIDATION; ELECTRON MICROSCOPY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER HISTOLOGY; LIVER NECROSIS; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; COCAINE; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; LIVER; MALE; MICE; MICE, INBRED ICR;

EID: 0031935306     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Benuck M, Reith MEA, Sershen H, Wiener HL and Lajtha A (1988) Oxidative metabolism of cocaine: Comparison of brain and liver. Proc Soc Exp Biol Med 190:7-13.
2. Bergmeyer HU, Scheibe P and Wahlefeld AW (1978) Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem 24:58-73.
3. Boelsterli UA and Goldlin C (1991) Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch Toxicol 65:351-360.
4. Boelsterli UA, Wolf A and Goldlin C (1993) Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology 18:1154-1161.
5. Charkoudian JC and Shuster L (1985) Electrochemistry of norcocaine nitroxide and related compounds: Implications for cocaine hepatotoxicity. Biochem Biophys Res Commun 130:1044-1051.
6. Evans MA and Harbison RD (1978) Cocaine-induced hepatotoxicity in mice. Toxicol Appl Pharmacol 45:739-754.
7. Evans MA (1983) Role of protein binding in cocaine-induced hepatic necrosis. J Pharmacol Exp Ther 224:73-79.
8. Freeman RW and Harbison RD (1981) Hepatic periportal necrosis induced by chronic administration of cocaine. Biochem Pharmacol 30:777-783.
9. Goldlin CR and Boelsterli UA (1991) Reactive oxygen species and non-peroxidative mechanisms of cocaine-induced cytotoxicity in rat hepatocyte cultures. Toxicology 69:79-91.
10. Gottfried MR, Kloss MW, Graham D, Rauckman EJ and Rosen GM (1986) Ultra structure of experimental cocaine hepatotoxicity. Hepatology 6:299-304.
11. Kanel GC, Cassidy W, Shuster L and Reynolds TB (1990) Cocaine-induced liver cell injury: Comparison of morphological features in man and in experimental models. Hepatology 11:646-651.
12. Kloss MW, Cavagnaro J, Rosen GM and Rauckman EJ (1982) Involvement of FAD-containing monooxygenase in cocaine-induced hepatotoxicity. Toxicol Appl Pharmacol 64:83-88.
13. Kloss MW, Rosen GM and Rauckman EJ (1983a) N-Demethylation of cocaine to norcocaine. Evidence for participation of cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 23:482-485.
14. Kloss MW, Rosen GM and Rauckman EJ (1983b) Evidence of enhanced lipid peroxidation after acute cocaine administration. Toxicol Lett 15:65-70.
15. Kloss MW, Rosen GM and Rauckman EJ (1984) Cocaine-mediated hepatotoxicity Biochem Pharmacol 33:169-173.
16. LeDuc BW, Sinclair PR, Shuster L, Sinclair JF, Evans JE and Greenblatt DJ (1993) Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: Role of cytochrome P-450 3A4. Pharmacology 46:294-300.
17. Lloyd RV, Shuster L and Mason RP (1993) Reexamination of the microsomal transformation of N-hydroxynorcocaine to norcocaine nitroxide. Mol Pharmacol 43:645-648.
18. Masini A, Gallesi D, Giovannini F, Trenti T and Ceccarelli D (1996) Membrane potential of hepatic mitochondria after acute cocaine administration in rats - the role of mitochondrial reduced glutathione. Hepatology 25:385-390.
19. Mehanny SZ and Abdel-Rahman MS (1991) Cocaine hepatotoxicity in mice: Histologic and enzymatic studies. Toxicol Pathol 19:24-29.
20. Misra AL, Pontani RB and Vadlamani NL (1979) Metabolism of norcocaine, N-hydroxynorcocaine and cocaine N-oxide in the rat. Xenobiotica 9:189-199.
21. Murayama N, Shimada M, Yamazoe Y, Sogawa K, Nakayama K, Fujii-Kuriyama Y and Kato R (1996) Distinct effects of phenobarbital and its N-methylated derivative on liver cytochrome P450 induction. Arch Biochem Biophys 328:184-192.
22. Pellinen P, Honkakoski P, Stenback F, Niemitz M, Alhava E, Pelkonen O, Lang MA and Pasanen M (1994) Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol 270:35-43.
23. Perino LE, Warren GH and Levine JS (1987) Cocaine-induced hepatotoxicity in humans. Gastroenterology 93:176-180.
24. Poet TS, McQueen CA and Halpert JR (1996) Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab Dispos 24:74-80.
25. Powell CJ, Connolly AK and Charles SJ (1991) Shifting necrosis: Butylated hydroxytoluene (BHT) and phenobarbital move cocaine-induced hepatic necrosis across the lobule. Toxicol Lett 55:171-178.
26. Powers JF, Alroy J and Shuster L (1992) Hepatic morphologic and biochemical changes induced by subacute cocaine administration. Toxicol Pathol 20:61-70.
27. Radin DR (1992) Cocaine-induced hepatic necrosis: CT demonstration. J Comput Assist Tomog 16:155-156.
28. Rauckman EJ, Rosen GM and Cavagnaro J (1982a) Norcocaine nitroxide: A potential hepatotoxic metabolite of cocaine. Mol Pharmacol 21:458-463.
29. Rauckman EJ, Kloss MW and Rosen G (1982b) Involvment of nitroxide radicals in cocaine-induced hepatotoxicity. Can J Chem 60:1614-1620.
30. Roberts SM, James RC and Harbison RD (1992a) Cocaine-induced hepatotoxicity, in Cocaine: Pharmacology, Physiology, and Clinical Strategies (Lakoski JM, Galloway MP and White FJ eds) pp 15-33, CRC Press Inc., Boca Raton, Florida.
31. Roberts SM, Roth L, Harbison RD and James RC (1992b) Cocaethylene hepatotoxicity in mice. Biochem Pharmacol 43:1989-1995.
32. Rosen GM, Kloss MW and Rauckman EJ (1982) Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide. Mol Pharmacol 22:529-531.
33. Roth L, Harbison RD, James RC, Tobin T and Roberts SM (1992) Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology 15:934-940.
34. Shuster L, Quimby F, Bates A and Thompson ML (1977) Liver damage from cocaine in mice. Life Sci 20:1035-1042.
35. Silva MO, Roth D, Reddy KR, Fernandez JA, Albores-Saavedra J and Schiff ER (1991) Hepatic dysfunction accompanying acute cocaine intoxication. J Hepotology 12:312-315.
36. Thompson ML, Shuster L and Shaw K (1979) Cocaine-induced hepatic necrosis in mice. The role of cocaine metabolism. Biochem Pharmacol 28:2389-95.
37. Winless IR, Dore S, Gopinath N, Tan J, Caeron R, Heathcote EJ, Blendis LM and Levy G (1990) Histopathology of cocaine hepatotoxicity. Gastroenterology 98:497-501.
38. Watanabe HK, Hoskins B and Ho IK (1987) Sensitivity difference to hepatotoxicity of cocaine in spontaneously hypertensive and Wistar Kyoto rats. Alcohol Drug Res 7:363-370.
39. Waxman D and Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577-592.